Pfizer

ZIRABEV - Cost

Last Updated: April 1st, 2024

HCPCS:

Q5118

HCPCS Code Descriptor:

Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg

Medicare Payment Limit:

The ZIRABEV Medicare Payment Limit is $20.755

Average Sale Price:

ZIRABEV ASP cost available once logged in. Zirabev is a biosimilar drug making the ASP calculation more complex. Zirabev's ASP is based on the average sale price of its biosimilar reference drug.

Medicare Co-Insurance Percentage:

The ZIRABEV Medicare Co-insurance percentage is 20%. ZIRABEV's Medicare Co-insurance amount is $4.15 per HCPCS unit.

APC Code:

The Zirabev APC Code is: 9348

APC Payment Limit:

The APC Payment Limit for ZIRABEV is available. Login to view.

Zirabev Cost Information:

Zirabev is a bevacizumab biosimilar to the reference drug Avastin. Zirabev’s HCPCS Code: Q5118 became effective October 1st, 2019, but the WAC and AWP pricing did not become effective until December 31st, 2019. While Zirabev’s WAC/AWP list pricing have remained steady since its effective date, the ASP has steadily decreased due to biosimilar competition. Since launch, Zirabev’s average sales price has dropped by over 70%.

ACCESS PRICING AND MORE BY REGISTERING

Zirabev’s wholesale acquisition cost (WAC) information was last updated on:
December 31, 2019
Zirabev’s average wholesale price (AWP) information was last updated on:
December 31, 2019